Literature DB >> 23261543

Phosphorylation of connexin43 on S279/282 may contribute to laminopathy-associated conduction defects.

Steven C Chen1, Brian K Kennedy, Paul D Lampe.   

Abstract

An understanding of the molecular mechanism behind the arrhythmic phenotype associated with laminopathies has yet to emerge. A-type lamins have been shown to interact and sequester activated phospho-ERK1/2(pERK1/2) at the nucleus. The gap junction protein connexin43 (Cx43) can be phosphorylated by pERK1/2 on S279/282 (pS279/282), inhibiting intercellular communication. We hypothesized that without A-type lamins, pS279/282 Cx43 will increase due to inappropriate phosphorylation by pERK1/2, resulting in decreased gap junction function. We observed a 1.6-fold increase in pS279/282 Cx43 levels in Lmna(-/-) mouse embryonic fibroblasts (MEFs) compared to Lmna(+/+), and 1.8-fold more pERK1/2 co-precipitated from Lmna(-/-) MEFs with Cx43 antibodies. We found a 3-fold increase in the fraction of non-nuclear pERK1/2 and a concomitant 2-fold increase in the fraction of pS279/282 Cx43 in Lmna(-/-) MEFs by immunofluorescence. In an assay of gap junctional function, Lmna(-/-) MEFs transferred dye to 60% fewer partners compared to Lmna(+/+) controls. These results are mirrored in 5-6 week-old Lmna(-/-) mice compared to their Lmna(+/+) littermates as we detect increased pS279/282 Cx43 in gap junctions by immunofluorescence and 1.7-fold increased levels by immunoblot. We conclude that increased pS279/282 Cx43 in the Lmna(-/-) background results in decreased cell communication and may contribute to the arrhythmic pathology in vivo.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23261543      PMCID: PMC3594536          DOI: 10.1016/j.yexcr.2012.12.014

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  47 in total

Review 1.  Blurring the boundary: the nuclear envelope extends its reach.

Authors:  Colin L Stewart; Kyle J Roux; Brian Burke
Journal:  Science       Date:  2007-11-30       Impact factor: 47.728

Review 2.  Nuclear shape, mechanics, and mechanotransduction.

Authors:  Kris Noel Dahl; Alexandre J S Ribeiro; Jan Lammerding
Journal:  Circ Res       Date:  2008-06-06       Impact factor: 17.367

3.  Ubiquitin protein ligase Nedd4 binds to connexin43 by a phosphorylation-modulated process.

Authors:  Kerstin Leykauf; Mojibrahman Salek; Jörg Bomke; Matthias Frech; Wolf-Dieter Lehmann; Matthias Dürst; Angel Alonso
Journal:  J Cell Sci       Date:  2006-09-01       Impact factor: 5.285

4.  Pathology and nuclear abnormalities in hearts of transgenic mice expressing M371K lamin A encoded by an LMNA mutation causing Emery-Dreifuss muscular dystrophy.

Authors:  Yuexia Wang; Alan J Herron; Howard J Worman
Journal:  Hum Mol Genet       Date:  2006-07-06       Impact factor: 6.150

5.  Differentiation of C2C12 myoblasts expressing lamin A mutated at a site responsible for Emery-Dreifuss muscular dystrophy is improved by inhibition of the MEK-ERK pathway and stimulation of the PI3-kinase pathway.

Authors:  Catherine Favreau; Erwan Delbarre; Jean-Claude Courvalin; Brigitte Buendia
Journal:  Exp Cell Res       Date:  2008-02-06       Impact factor: 3.905

6.  Lamin A/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy.

Authors:  Sharie B Parks; Jessica D Kushner; Deirdre Nauman; Donna Burgess; Susan Ludwigsen; Amanda Peterson; Duanxiang Li; Petra Jakobs; Michael Litt; Charles B Porter; Peter S Rahko; Ray E Hershberger
Journal:  Am Heart J       Date:  2008-03-12       Impact factor: 4.749

7.  High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics.

Authors:  J Peter van Tintelen; Robert M W Hofstra; Hilga Katerberg; Tom Rossenbacker; Ans C P Wiesfeld; Gideon J du Marchie Sarvaas; Arthur A M Wilde; Irene M van Langen; Eline A Nannenberg; Anneke J van der Kooi; Marian Kraak; Isabelle C van Gelder; Dirk Jan van Veldhuisen; Yvonne Vos; Maarten P van den Berg
Journal:  Am Heart J       Date:  2007-09-14       Impact factor: 4.749

8.  Activation of MAPK in hearts of EMD null mice: similarities between mouse models of X-linked and autosomal dominant Emery Dreifuss muscular dystrophy.

Authors:  Antoine Muchir; Paul Pavlidis; Gisèle Bonne; Yukiko K Hayashi; Howard J Worman
Journal:  Hum Mol Genet       Date:  2007-06-13       Impact factor: 6.150

9.  Activation of MAPK pathways links LMNA mutations to cardiomyopathy in Emery-Dreifuss muscular dystrophy.

Authors:  Antoine Muchir; Paul Pavlidis; Valérie Decostre; Alan J Herron; Takuro Arimura; Gisèle Bonne; Howard J Worman
Journal:  J Clin Invest       Date:  2007-04-19       Impact factor: 14.808

10.  Desmin immunolocalisation in autosomal dominant Emery-Dreifuss muscular dystrophy.

Authors:  Richard J Piercy; Haiyan Zhou; Lucy Feng; Ana Pombo; Francesco Muntoni; Susan C Brown
Journal:  Neuromuscul Disord       Date:  2007-02-27       Impact factor: 4.296

View more
  11 in total

Review 1.  Specific Cx43 phosphorylation events regulate gap junction turnover in vivo.

Authors:  Joell L Solan; Paul D Lampe
Journal:  FEBS Lett       Date:  2014-02-04       Impact factor: 4.124

Review 2.  Connexin 43 is an emerging therapeutic target in ischemia/reperfusion injury, cardioprotection and neuroprotection.

Authors:  Rainer Schulz; Philipp Maximilian Görge; Anikó Görbe; Péter Ferdinandy; Paul D Lampe; Luc Leybaert
Journal:  Pharmacol Ther       Date:  2015-06-11       Impact factor: 12.310

Review 3.  Lamin A/C Cardiomyopathies: Current Understanding and Novel Treatment Strategies.

Authors:  Xi Wang; Allyson Zabell; Wonshill Koh; W H Wilson Tang
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-03

4.  Cardiomyocyte FGF signaling is required for Cx43 phosphorylation and cardiac gap junction maintenance.

Authors:  Takashi Sakurai; Mariko Tsuchida; Paul D Lampe; Masahiro Murakami
Journal:  Exp Cell Res       Date:  2013-06-04       Impact factor: 3.905

Review 5.  When lamins go bad: nuclear structure and disease.

Authors:  Katherine H Schreiber; Brian K Kennedy
Journal:  Cell       Date:  2013-03-14       Impact factor: 41.582

6.  AFM single-cell force spectroscopy links altered nuclear and cytoskeletal mechanics to defective cell adhesion in cardiac myocytes with a nuclear lamin mutation.

Authors:  Thomas Lanzicher; Valentina Martinelli; Carlin S Long; Giorgia Del Favero; Luca Puzzi; Massimo Borelli; Luisa Mestroni; Matthew R G Taylor; Orfeo Sbaizero
Journal:  Nucleus       Date:  2015       Impact factor: 4.197

7.  MicroRNA-23a participates in estrogen deficiency induced gap junction remodeling of rats by targeting GJA1.

Authors:  Ning Wang; Lu-Yao Sun; Shou-Chen Zhang; Ran Wei; Fang Xie; Jing Liu; Yan Yan; Ming-Jing Duan; Lin-Lin Sun; Ying-Hui Sun; Hui-Fang Niu; Rong Zhang; Jing Ai
Journal:  Int J Biol Sci       Date:  2015-02-15       Impact factor: 6.580

Review 8.  Current insights into LMNA cardiomyopathies: Existing models and missing LINCs.

Authors:  Daniel Brayson; Catherine M Shanahan
Journal:  Nucleus       Date:  2017-01-02       Impact factor: 4.197

Review 9.  Role of Lamin A/C Gene Mutations in the Signaling Defects Leading to Cardiomyopathies.

Authors:  Andrea Gerbino; Giuseppe Procino; Maria Svelto; Monica Carmosino
Journal:  Front Physiol       Date:  2018-09-25       Impact factor: 4.566

Review 10.  Updated clinical overview on cardiac laminopathies: an electrical and mechanical disease.

Authors:  G Peretto; S Sala; S Benedetti; C Di Resta; L Gigli; M Ferrari; P Della Bella
Journal:  Nucleus       Date:  2018       Impact factor: 4.197

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.